A student sued GlaxoSmithKline (GSK), a big pharmaceutical company in the UK. The 26-year-old claimed that she got the wrong dosage of a medication causing her skin to burn off.
The Wrong Dosage
Khaliah Shaw is a graduate pupil at both Georgia College and State University in America. She was prescribed the wrong dosage of anti-seizure medication lamotrigine, known as Lamictal in the US in 2014.
Few weeks of taking the medication, Shaw claimed that her body was full of blisters. She said she was “in excruciating pain” and felt like she was “on fire”.
The experience prompted her finding of Stevens-Johnson disorder, an uncommon skin issue that usually comes as a reaction because of a medication or a wrong dosage.
For five weeks, Shaw’s skin gradually peeled off and she was in a medically induced coma. The disorder caused Shaw scars on her skin as well as slowly losing her vision. In addition, her finger nails may never grow back.
The disorder has no cure and doctors said that she may relapse.
“They’re telling me this could happen again, and they’re telling me if it did happen again, that it would be worse,” Ms Shaw said.
Consequently, Shaw sued GSK for marketing the medicine without revealing its risks. She demanded more than $3.45 million.
It is not a first for GSK to get sued because of suspected healthcare fraud.
In 2012, GSK pleaded guilty to marketing drugs illegally and covering up safety data from the Food and Drug Administration (FDA). GSK then approved on to paying $3bn.
After a woman sued GSK because of her husband who committed suicide while taking a version of Paxil, antidepressant medicine. Within this month, a jury in Chicago then ruled that GSK should pay $3m to the women.
However, GSK didn’t immediately commented on the report.